Health Trials

About this trial

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.

Eligibility criteria

Qualifiers

Patients diagnosed with or suspected to have a mitochondrial disorder

Adult carriers of known mitochondrial DNA mutations

Patients with laboratory analysis indicative of a mitochondrial disorder.

Medical information and tissue samples are also accepted from deceased individuals who fulfill the above criteria.

Disqualifiers

Patients not suspected of having a mitochondrial disorder

Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that affects mitochondrial function.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group

Locations

17
Canada
McMaster UniversityON L8N 3Z5, HamiltonOntario, Canada
United States
California
University of California San Diego92103, San Diego United States
Lucile Packard Children's Hospital94305, Stanford United States
Colorado
Children's Hospital of Colorado80045, Aurora United States

Sponsors and collaborators

Columbia University

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Source ClinicalTrials.gov